Table 3.
Patients with ICC metastases treated by SMWA.
| Patient | Age at SMWA | Gender | Tumor Stage | Previous Treatment | Adjuvant CTX | Location Metastasis Segment | Size of Ablated Metastasis | Complications > Dindo IIIa |
| 1 | 72 | W | T2aN1M0 L0V0Pn1 G1 R0 | ALPPS | Gemcitabine | II | 32 | no |
| 2 | 37 | W | T1N0M1 L0V0Pn0 R0 G3 | Right hepatectomy + metastectomy left liver | Xeloda | II | 15 | no |
| 3 | 58 | M | T1N0M0 Ln1V0Pn0R1 G3 | ALPPS | Gemcitabine/ Capecitabine | IVb | 26 & 25 | no |
| 4 | 66 | W | T2N0M0 Ln0V1Pn0R1 G2 | Extended left hepatectomy | none | VIII | 17 | no |
| 5 | 56 | M | T2aN0M0 Ln0V0Pn1R0 G1 | ALLPS | none | III | 6 | abscess |
| Patient | Local Recurrence | Time to Recurrence (Months) | Treatment of Recurrence | Death | OS after SMWA (Months) |
OS after
Initial Diagnosis |
Overall Disease Progression | |
| 1 | yes | 5 | SBRT | yes | 19 | 45 | yes | |
| 2 | no | no | 20 | 34 | no | |||
| 3 | yes | 3 | CTX | yes | 5.5 | 35 | yes | |
| 4 | no | yes | 6.5 | 15 | no | |||
| 5 | no | no | 1 | 25 | no | |||
Gender: M = male, F = female; OS = overall survival; CTX = chemotherapy; SBRT = stereotactic body radiotherapy; ALPPS = Associating Liver Partition and Portal Vein Ligation.